Ntla stock forecast.

Dec 1, 2023 · View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and... For Intellia Therapeutics stock forecast for 2023, 2 predictions are offered for each month of 2023 with average Intellia Therapeutics stock forecast of $23.66, a high forecast of $23.9, and a low forecast of $23.43. The average Intellia Therapeutics stock forecast 2023 represents a 2.17% increase from the last price of $23.1599998474121.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Intellia Therapeutics ( NASDAQ: NTLA) added ~13% on Thursday to reach the highest level in more than two months after the gene-editing company reported its Q1 2023 financials alongside updates ...See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

A high-level overview of Intellia Therapeutics, Inc. (NTLA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Sep 5, 2023 · (See NTLA stock forecast) Pacific Biosciences . We’ll stay in the biotech space for the next Wood-backed name, although Pacific Biosciences operates in a different segment. The life science ...

NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 …

Find the latest Intellia Therapeutics, Inc. NTLA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business.Intellia Therapeutics Stock Chart and Share Price Forecast, Short-Term "NTLA" Stock Prediction for Next Days and Weeks Walletinvestor.com Intellia Therapeutics Inc (NTLA) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00.

(See NTLA stock forecast on TipRanks) To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of ...

Current. -$1.48. 1 Month Ago. -$1.60. 3 Months Ago. -$1.63. Intellia Therapeutics Inc. analyst estimates, including NTLA earnings per share estimates and analyst recommendations.

Find real-time NKLA - Nikola Corp stock quotes, company profile, news and forecasts from CNN Business.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.What are analysts forecasts for Intellia Therapeutics stock? The 61 analysts offering price forecasts for Intellia Therapeutics have a median target of 93.70, with a high estimate of 180.00 and a ...Jun 8, 2023 · Here, I discuss the central investing thesis for its fellow CRISPR/Cas9 gene-editing specialist, Intellia Therapeutics (NTLA 2.54%). This biotech growth stock, too, stands out as a potential ... Discover historical prices for NTLA stock on Yahoo Finance. View daily, weekly or monthly format back to when Intellia Therapeutics, Inc. stock was issued.Discover historical prices for SAVA stock on Yahoo Finance. View daily, weekly or monthly format back to when Cassava Sciences, Inc. stock was issued.

Intellia's Q1 2023 financial report shows a cash position of $1.2 billion, with collaboration revenue rising to $12.6 million and a net loss of $103.1 million. The success of NTLA-2002 in further ...Analyst Forecast According to 21 analysts, the average rating for NTLA stock is "Buy." The 12-month stock price forecast is $77.4, which is an increase of 161.22% from the latest price.The Vanguard Group, Inc. is the second largest shareholder owning 9.2% of common stock, and BlackRock, Inc. holds about 9.1% of the company stock. Furthermore, CEO John Leonard is the owner of 0.9 ...The stock market has always been a volatile environment – but the last several weeks have seen an increase in that phenomenon. The bull market of 2021 shifted into reverse in January, and increased intraday swings, along with a partial reversal of losses, have been the order of the day in February. Unsurprisingly, much of the market’s …The average Intellia Therapeutics stock price prediction forecasts a potential upside of 203.75% from the current NTLA share price of $25.50. What is NTLA's forecast return on assets (ROA) for 2023-2026?Intellia Therapeutics (NTLA) Stock Forecast & Price Prediction. Estimation of the future price movement of Intellia Therapeutics stock, based on various factors such as …

About the Visa, Inc. stock forecast. As of 2023 December 02, Saturday current price of V stock is 256.450$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Visa Inc - Class A stock price as been showing a rising tendency so we believe that similar market segments were very popular …

Intellia Therapeutics ( NTLA -3.53%) works in the up-and-coming area of gene editing. Invitae ( NVTA 0.75%) specializes in genetic testing. Both stocks have declined over the past year. But Wall ...NTLA - Free Report) reported second-quarter 2023 loss of $1.40 per share, wider than the Zacks Consensus Estimate of a loss of $1.32. In the year-ago quarter, Intellia incurred a loss of $1.33 per ...The 24 analysts offering 1 year price forecasts for NTLA have a max estimate of — and a min estimate of —. Analyst rating Based on 27 analysts giving stock ratings to NTLA in …Stock Price Forecast. The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 72.00, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +175.23% increase from the last price of 26.16. The Invitae Corp ( NVTA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $3.8754, representing a +617.26% increase from the current price of $0.5403. The highest analyst price target is $7.6988, and the lowest is $0.0519. Based on our technical indicators, the current sentiment is ...May 10, 2023 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance

What are analysts forecasts for Intellia Therapeutics stock? The 61 analysts offering price forecasts for Intellia Therapeutics have a median target of 93.70, with a high estimate of 180.00 and a ...

Intellia Therapeutics (NTLA) Stock Forecast & Price Prediction. Estimation of the future price movement of Intellia Therapeutics stock, based on various factors such as …

Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...Stock Price Forecast. According to 20 stock analysts, the average 12-month stock price forecast for NTLA stock stock is $77.4, which predicts an increase …The stock price of Intellia Therapeutics (NASDAQ: NTLA), a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a solid 15% rise over the last five trading days ...Some of the best biotech stocks to buy according to hedge funds include Pfizer Inc. (NYSE: PFE ), Illumina, Inc. (NASDAQ: ILMN ), and United Therapeutics Corporation (NASDAQ: UTHR ).Intellia was founded in 2014 and went public in 2016, raising net proceeds of $112.1 million at $18 per share. The stock currently trades around $36.00 a share, translating to a market cap of $3. ...The above table shows the analyst NTLA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$30.65As of July 20, 2023, 4:00 PM CST, Intellia Therapeutics Inc’s stock price was $43.28. Intellia Therapeutics Inc is down 5.13% from its previous closing price of $45.62. During the last market session, Intellia Therapeutics Inc’s stock traded between $44.60 and $46.00. Currently, there are 87.77 million shares of Intellia Therapeutics Inc ...Stock Price Forecast. The 25 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 90.10, with a high estimate of 116.00 and a low estimate of 71.00. The ...

Jun 25, 2023 · But Intellia has two programs in early-stage trials that could make this a monster stock in the future. NTLA-2001 is an in vivo gene-editing treatment for transthyretin amyloidosis, a condition ... AAPL. 189.69. -0.01%. 49.41M. View today's Intellia Therapeutics Inc stock price and latest NTLA news and analysis. Create real-time notifications to follow any changes in the live stock price.The average twelve-month price prediction for Intellia Therapeutics is $77.70 with a high price target of $136.00 and a low price target of $40.00. Learn more on NTLA's analyst rating history. Do Wall Street analysts like Intellia Therapeutics more than its competitors?Intellia has declined in the double digits over the past year. Superstar investor Cathie Wood is increasing her bet on a cutting-edge technology that could transform the treatment of many diseases ...Instagram:https://instagram. reits to buy nowxxmbhow much to rent a tesla for a daymichael burry For their last quarter, Intellia Therapeutics (NTLA) reported earnings of -$1.40 per share, missing the Zacks Consensus Estimate of -$1.32 per share. This reflects a negative earnings surprise of ...Shares of Intellia Therapeutics, Inc. (NTLA) have gained 23.5% over the past four weeks to close the last trading session at $43.19, but there could still be a solid upside left in the stock if ... plus 500 brokertesla prediction In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors nyse tds Intellia Therapeutics, Inc. CAMBRIDGE, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing ...The 12-month stock price forecast is $69.88, which is an increase of 1.79% from the latest price. Price Target. $69.88 (1.79% upside) Analyst Consensus: Buy. Stock Forecasts. News. All; Videos; Press Press Releases; Conversation; ... Intellia Therapeutics Inc. NTLA, -0.28% shares gained 6.4% premarket on Monday after the clinical stage …Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...